SecurityAP / Ampco-Pittsburgh Corp. (032037103)
IndustryPumps and Pumping Equipment
Institutional Owners61
Institutional Shares7,807,744 - 63.16%
Common Shares Outstanding12,362,198 shares (as of 2018-03-31)
Institutional Value$ 416,578,000 USD

Institutional Stock Ownership and Shareholders()

AP / Ampco-Pittsburgh Corp. Institutional Ownership

Ampco-Pittsburgh Corp. (NYSE:AP) has 61 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7,807,744 shares. Largest shareholders include Gamco Investors, Inc. Et Al, Dimensional Fund Advisors Lp, BlackRock Inc., Gabelli Funds Llc, Teton Advisors, Inc., Vanguard Group Inc, QV Investors Inc., Walthausen & Co., LLC, BlackRock Fund Advisors, and Renaissance Technologies LLC.
Ampco-Pittsburgh Corp. (NYSE:AP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/ap"><img src="https://images.fintel.io/us-ap-so.png" alt="AP / Ampco-Pittsburgh Corp. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 52,495 55,649 6.01 651 495 -23.96
2018-05-15 13F-HR RBF Capital, LLC 50,656 50,656 0.00 628 451 -28.18
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 673,086 715,763 6.34 8,346 6,370 -23.68
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1,344 0 -100.00 17 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 12,576 0 -100.00 185 0 -100.00
2018-05-11 13F-HR MACQUARIE GROUP LTD 2,973 0 -100.00 37 0 -100.00
2018-05-15 13F-HR FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 135,000 165,000 22.22 1,674 1,469 -12.25
2018-05-15 13F-HR MENTA CAPITAL LLC 18,717 17,117 -8.55 232 152 -34.48
2018-05-15 13F-HR VANGUARD GROUP INC 476,783 472,076 -0.99 5,912 4,202 -28.92
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 67,981 68,931 1.40 842 613 -27.20
2018-05-11 13F-HR Parisi Gray Wealth Management 1,325 1,325 0.00 17 13 -23.53
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 3,539 1,814 -48.74 44 16 -63.64
2018-05-15 13F-HR BARCLAYS PLC 1,733 9,588 453.26 21 85 304.76
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 19,621 0 -100.00 243 0 -100.00
2018-05-14 13F-HR Adirondack Research & Management Inc. 83,141 128,752 54.86 1,031 1,146 11.15
2018-05-15 13F-HR Brandywine Global Investment Management, LLC 7,349 0 -100.00 92 0 -100.00
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 77,399 50,499 -34.75 960 449 -53.23
2018-05-14 13F-HR TEACHERS ADVISORS INC 17,087 17,087 0.00 212 152 -28.30
2018-05-14 13F-HR Walthausen & Co., LLC 289,780 289,080 -0.24 3,593 2,573 -28.39
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 19,891 0 -100.00 293 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 2,888 3,098 7.27 36 27 -25.00
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 3,200 0 28
2017-01-13 13F-HR MetLife Securities, Inc 50 0 -100.00 1 0 -100.00
2018-05-09 13F-HR GAMCO INVESTORS, INC. ET AL 1,428,329 1,438,575 0.72 17,711 12,803 -27.71
2018-05-15 13F-HR PUTNAM INVESTMENTS LLC 0 81,058 0 721
2018-05-09 13F-HR NORTHERN TRUST CORP 104,285 101,638 -2.54 1,293 905 -30.01
2018-05-04 13F-HR MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 38,375 36,720 -4.31 475,850 326,808 -31.32
2017-02-10 13F-HR BlackRock Investment Management, LLC 33,886 33,886 0.00 376 568 51.06
2017-02-10 13F-HR BlackRock Fund Advisors 238,401 280,053 17.47 2,644 4,691 77.42
2018-05-08 13F-HR ClariVest Asset Management LLC 15,399 0 -100.00 191 0 -100.00
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 42,000 42,000 0.00 521 374 -28.21
2018-05-15 13F-HR Clearbridge Investments, LLC 1,600 1,600 0.00 20 14 -30.00
2018-05-01 13F-HR WEDGE CAPITAL MANAGEMENT L L P/NC 48,300 58,387 20.88 599 520 -13.19
2018-05-11 13F-HR Cutler Group LP 298 0 -100.00 3 0 -100.00
2018-05-08 13F-HR US BANCORP \DE\ 23,768 22,763 -4.23 295 203 -31.19
2018-05-04 13F-HR Boston Partners 106,140 75,275 -29.08 1,316 670 -49.09
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 5,859 5,560 -5.10 73 49 -32.88
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 267,831 269,245 0.53 2,970 4,510 51.85
2018-05-09 13F-HR BlackRock Inc. 600,154 586,666 -2.25 7,442 5,220 -29.86
2018-05-15 13F-HR UBS Group AG 927 0 -100.00 11 0 -100.00
2018-05-17 13F-HR Legal & General Group Plc 1,324 1,324 0.00 16 12 -25.00
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 2,607 1,799 -30.99 32,327 16,011 -50.47
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 18,900 18,900 0.00 235 169 -28.09
2018-05-09 13F-HR GABELLI FUNDS LLC 528,008 531,208 0.61 6,547 4,728 -27.78
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 3,061 3,003 -1.89 38 27 -28.95
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 8,800 8,800 0.00 109 78 -28.44
2018-05-15 13F-HR 22NW, LP 70,672 121,269 71.59 876 1,079 23.17
2018-05-08 13F-HR Cranbrook Wealth Management, LLC 473 473 0.00 6 4 -33.33
2018-05-14 13F-HR ZACKS INVESTMENT MANAGEMENT 10,231 91
2018-05-15 13F-HR Ancora Advisors, LLC 0 74,090 0 659
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 200 100 -50.00 2 1 -50.00
2018-05-07 13F-HR QUANTUM CAPITAL MANAGEMENT 80,795 136,562 69.02 1,002 1,215 21.26
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 2,187 521 -76.18 27 5 -81.48
2018-05-14 13F-HR Renaissance Technologies LLC 271,200 274,800 1.33 3,363 2,446 -27.27
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 14,950 15,830 5.89 185 141 -23.78
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 9,329 9,355 0.28 116 83 -28.45
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 2,500 2,500 0.00 31 22 -29.03
2018-05-14 13F-HR Royce & Associates LLC 249,830 249,830 0.00 3,098 2,223 -28.24
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 24,141 22,454 -6.99 299 200 -33.11
2018-05-15 13F-HR Invesco Ltd. 19,650 24,296 23.64 244 216 -11.48
2018-05-15 13F-HR DEUTSCHE BANK AG\ 19,599 9,393 -52.07 242 82 -66.12
2018-05-14 13F-HR MORGAN STANLEY 25,328 29,881 17.98 314 266 -15.29
2018-05-15 13F-HR SALEM INVESTMENT COUNSELORS INC 25 0 -100.00 0 0
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 667 667 0.00 8 6 -25.00
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 13,852 13,852 0.00 172 123 -28.49
2018-05-11 13F-HR Delpha Capital Management, Llc 230 0 -100.00 3 0 -100.00
2018-04-24 13F-HR QV Investors Inc. 322,875 323,865 0.31 4,003 2,882 -28.00
2018-05-10 13F-HR JP Morgan Chase & Co 1,882 1,751 -6.96 23 16 -30.43
2018-05-14 13F-HR PHILADELPHIA TRUST CO 164,650 73,200 -55.54 2,042 651 -68.12
2018-05-15 13F-HR Bank of New York Mellon Corp 98,026 109,917 12.13 1,215 978 -19.51
2017-02-10 13F-HR BlackRock Advisors LLC 5,469 4,972 -9.09 61 83 36.07
2018-05-15 13F-HR STATE STREET CORP 133,778 134,840 0.79 1,659 1,200 -27.67
2018-05-09 13F-HR Teton Advisors, Inc. 471,844 515,000 9.15 5,851 4,584 -21.65

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

DXCM: A Leader In The Shift From Prick To Click

2018-07-18 seekingalpha
The CGM market is robust and underpenetrated, with a current TAM of approximately $41 billion based on my market estimates. (4-0)

Achaogen: Zemdri To The Rescue

2018-07-10 seekingalpha
I hitched a recent ride on Achaogen in hopes that it would rise from its downdraft. (15-2)

Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q1 2018 Update

2018-05-17 seekingalpha
Fairfax Financial’s largest five stakes are BlackBerry, Resolute Forest Products, Kennedy-Wilson, USG, and Intrepid Potash. They together account for ~85% of the US long assets. (218-9)

New Strong Sell Stocks for April 20th

2018-04-20 zacks
American Homes 4 Rent (AMH - Free Report) is a provider of single-family home rental services. The Zacks Consensus Estimate for its current year earnings has been revised 4.3% downward over the last 60 days. (93-0)

New Strong Sell Stocks for April 18th

2018-04-18 zacks
Acorda Therapeutics, Inc. (ACOR - Free Report) is a developer of therapies for neurological disorders. The Zacks Consensus Estimate for its current year earnings has been revised 93.2% downward over the last 60 days. (43-0)

CUSIP: 032037103